Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07242599
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
4810
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Cerebral Infarction
Interventions
COMBINATION_PRODUCT:
High target group
COMBINATION_PRODUCT:
Low target group
Sponsor
Beijing Tiantan Hospital